Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus

The efficiency of glucocorticoid (GC) therapy for systemic lupus erythematosus (SLE) is beyond question and is confirmed by the experience gained over many decades of their use. However, there are many problems with prolonged GC use, even in its low and medium doses. In particular, the development o...

Full description

Bibliographic Details

Published in:	Современная ревматология
Main Authors:	S. K. Solovyev, E. A. Aseeva, E. L. Nasonov, A. M. Lila, G. M. Koilubaeva
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2020-03-01
Subjects:	systemic lupus erythematosus glucocorticoids irreversible organ damages biological agents
Online Access:	https://mrj.ima-press.net/mrj/article/view/986